TrademarkDir
OTOGENETICS CORPORATION
LIVE

Serial Number

85808291

Owner

Otogenetics Corporation

Attorney

Ashley N. Klein

First Use Date

Aug 1, 2010

Filing Date

Dec 20, 2012

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

OTOGENETICS CORPORATION Trademark

Serial Number: 85808291 • Registration: 5034020

OTOGENETICS CORPORATION is a trademark filed by Otogenetics Corporation on December 20, 2012. The trademark is classified under Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

Otogenetics Corporation (5 trademarks)

Suite 100
Atlanta, GA 30360

Entity Type: 03

Trademark Details

Filing Date

December 20, 2012

Registration Date

September 6, 2016

First Use Anywhere

August 1, 2010

First Use in Commerce

January 1, 2011

Published for Opposition

June 21, 2016

Goods & Services

Consulting services in the fields of biotechnology, pharmaceutical research and development and genetic science; Consulting services in the fields of biotechnology, pharmaceutical research and development, laboratory testing, diagnostics, and pharmacogenetics; Providing information on the subject of scientific research in the field of biochemistry and biotechnology; Providing laboratory research services in the field of gene expression, namely, cancer biology; Research and development in the pharmaceutical and biotechnology fields; Testing, inspection, research, or development of pharmaceutical preparations for gene therapy

Filing History

TEAS SECTION 8 & 9 RECEIVED
May 18, 2026 E89R
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Sep 30, 2025 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Sep 30, 2025 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Sep 30, 2025 REAP
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Sep 6, 2025 REM2
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Jun 11, 2022 NA85
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Jun 11, 2022 C15A
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Jun 11, 2022 APRE
TEAS SECTION 8 & 15 RECEIVED
Dec 22, 2021 E815
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Oct 25, 2021 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Oct 25, 2021 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Oct 25, 2021 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Oct 25, 2021 REAP
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Oct 25, 2021 COAR
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Sep 6, 2021 REM1
REGISTERED-PRINCIPAL REGISTER
Sep 6, 2016 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jun 21, 2016 NPUB
PUBLISHED FOR OPPOSITION
Jun 21, 2016 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jun 1, 2016 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
May 17, 2016 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
May 12, 2016 CNSA
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Nov 12, 2015 RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
May 12, 2015 RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Nov 12, 2014 RCSC
ASSIGNED TO EXAMINER
Aug 11, 2014 DOCK
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
May 12, 2014 RCSC
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Nov 10, 2013 GNS3
LETTER OF SUSPENSION E-MAILED
Nov 10, 2013 GNSL
SUSPENSION LETTER WRITTEN
Nov 10, 2013 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 21, 2013 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 21, 2013 CRFA
ASSIGNED TO LIE
Oct 15, 2013 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Oct 12, 2013 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Apr 13, 2013 GNRN
NON-FINAL ACTION E-MAILED
Apr 13, 2013 GNRT
NON-FINAL ACTION WRITTEN
Apr 13, 2013 CNRT
ASSIGNED TO EXAMINER
Apr 6, 2013 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 8, 2013 NWOS
NEW APPLICATION ENTERED
Dec 24, 2012 NWAP

Related Trademarks

More from this Owner

GXVISION

GXVISION

GXVISION

GXVISION

GXVISION

GXVISION

SEROVISION COVID-19 IGM/IGG ANTIBODY RAPID TEST

SEROVISION COVID-19 IGM/IGG ANTIBODY RAPID TEST

SEROVISION COVID-19 IGM/IGG ANTIBODY RAPID TEST

SEROVISION COVID-19 IGM/IGG ANTIBODY RAPID TEST

SEROVISION COVID-19 IGM/IGG ANTIBODY RAPID TEST

SEROVISION COVID-19 IGM/IGG ANTIBODY RAPID TEST